Opinion: GE Crops Are Seen Through a Warped Lens

Risks that pertain to all manner of new crops are often misattributed to genetic engineering. This distorts the public’s view of the technology.

Written byRod A. Herman, Nicholas P. Storer, and Bryan Delaney
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © istock.com, B&M Noskowski

Public perception of genetically engineered (GE) crops is being manipulated by organizations that purport to represent the interests of consumers and the environment. These anti-GE groups publish stories discussing risks as if they are unique to GE crops, not acknowledging that similar risks are accepted in traditional agriculture. Meanwhile, environmental, health, and economic benefits of GE crops become lost in a sea of alleged dangers, such as triggering allergies in consumers or harming the environment. As a result, efforts to engineer crops with agronomic traits or improved nutrition face an uphill battle to gain acceptance.

Of course, there are potential risks involved with growing GE crops, which are assessed during regulatory reviews prior to cultivation, and these must be taken into consideration when assessing the potential benefits of such plants. But the same can be said for any food item entering the market. Conventional crop ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies